Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Doxazosin

Related Products

Hot Products

Name

Doxazosin

EINECS N/A
CAS No. 74191-85-8 Density 1.371 g/cm3
PSA 175.02000 LogP 2.88670
Solubility N/A Melting Point 289-290 °C
Formula C23H25N5O5 Boiling Point 718 °C at 760 mmHg
Molecular Weight 451.482 Flash Point 388 °C
Transport Information N/A Appearance N/A
Safety Risk Codes R23/24/25; R34; R40; R43; R36/37/38; R38
Molecular Structure Molecular Structure of 74191-85-8 ([4-(4-Amino-6,7-dimethoxy-quinazolin-2- yl)piperazin-1-yl]-(2,5-dioxabi cyclo[4.4.0]deca-6,8,10-trien-4-yl)methanone) Hazard Symbols T,Xi
Synonyms

Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-(9CI);[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](2,3-dihydro-1,4-benzodioxin-2-yl)methanone;Doxazosine;UK 33274;piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-;2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)pipérazin-1-yl]-6,7-diméthoxyquinazolin-4-amine;

Article Data 9

Doxazosin Synthetic route

23680-84-4

2-chloro-6,7-dimethoxyquinazolin-4-amine

70918-00-2

(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(piperazin-1-yl)methanone

74191-85-8

doxazosin

Conditions
ConditionsYield
In butan-1-ol Reflux;88%
In butan-1-ol for 5h; Heating;83%
3663-80-7, 34385-93-8, 70918-53-5, 70918-54-6

1,4-benzodioxane-2-carboxylic acid

60547-97-9

4-amino-6,7-dimethoxy-2-piperazin-1-ylquinazoline

74191-85-8

doxazosin

Conditions
ConditionsYield
With 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 20℃; for 5.16667h;80%
4739-94-0

ethyl 2,3-dihydro-1,4-benzodioxin-2-carboxylate

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 65 percent / 6 h / 70 - 80 °C
2: 83 percent / butan-1-ol / 5 h / Heating
View Scheme
120-80-9

benzene-1,2-diol

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 85 percent / potassium hydroxide; polyethylene glycol-400; potassium carbonate / toluene / 3.75 h / Heating
2: 65 percent / 6 h / 70 - 80 °C
3: 83 percent / butan-1-ol / 5 h / Heating
View Scheme
1246188-97-5

(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(1H-imidazol-1-yl)methanone

60547-97-9

4-amino-6,7-dimethoxy-2-piperazin-1-ylquinazoline

74191-85-8

doxazosin

Conditions
ConditionsYield
In tetrahydrofuran at 25 - 28℃; Product distribution / selectivity;
3663-80-7, 34385-93-8, 70918-53-5, 70918-54-6

1,4-benzodioxane-2-carboxylic acid

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrahydrofuran / 2 h / 20 - 25 °C
2: tetrahydrofuran / 25 - 28 °C
View Scheme
Multi-step reaction with 3 steps
1: N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate / dichloromethane / -15 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 1.25 h / 0 - 20 °C
3: butan-1-ol / Reflux
View Scheme
3663-82-9

2-hydroxymethyl-2,3-dihydrobenzo[1,4]dioxin

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium hydroxide; potassium permanganate / water / 0 °C
2: 1,1'-carbonyldiimidazole / tetrahydrofuran / 5.17 h / 0 - 20 °C
View Scheme
Multi-step reaction with 4 steps
1: potassium hydroxide; potassium permanganate / water / 0 °C
2: N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate / dichloromethane / -15 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 1.25 h / 0 - 20 °C
4: butan-1-ol / Reflux
View Scheme
533-58-4

2-Iodophenol

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: potassium carbonate / N,N-dimethyl-formamide; water; ethyl acetate / 24 h / 50 °C
2: sodium tetrahydroborate / tetrahydrofuran; methanol / 6 h / 0 °C
3: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
4: potassium hydroxide; potassium permanganate / water / 0 °C
5: 1,1'-carbonyldiimidazole / tetrahydrofuran / 5.17 h / 0 - 20 °C
View Scheme
Multi-step reaction with 7 steps
1: potassium carbonate / N,N-dimethyl-formamide; water; ethyl acetate / 24 h / 50 °C
2: sodium tetrahydroborate / tetrahydrofuran; methanol / 6 h / 0 °C
3: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
4: potassium hydroxide; potassium permanganate / water / 0 °C
5: N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate / dichloromethane / -15 °C / Inert atmosphere
6: trifluoroacetic acid / dichloromethane / 1.25 h / 0 - 20 °C
7: butan-1-ol / Reflux
View Scheme

C13H15IO5

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium tetrahydroborate / tetrahydrofuran; methanol / 6 h / 0 °C
2: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
3: potassium hydroxide; potassium permanganate / water / 0 °C
4: 1,1'-carbonyldiimidazole / tetrahydrofuran / 5.17 h / 0 - 20 °C
View Scheme
Multi-step reaction with 6 steps
1: sodium tetrahydroborate / tetrahydrofuran; methanol / 6 h / 0 °C
2: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
3: potassium hydroxide; potassium permanganate / water / 0 °C
4: N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate / dichloromethane / -15 °C / Inert atmosphere
5: trifluoroacetic acid / dichloromethane / 1.25 h / 0 - 20 °C
6: butan-1-ol / Reflux
View Scheme

2-(2-iodophenoxy)propane-1,3-diol

74191-85-8

doxazosin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
2: potassium hydroxide; potassium permanganate / water / 0 °C
3: 1,1'-carbonyldiimidazole / tetrahydrofuran / 5.17 h / 0 - 20 °C
View Scheme
Multi-step reaction with 5 steps
1: copper(l) iodide; 1,10-Phenanthroline; caesium carbonate / toluene / 90 °C / Sealed tube; Inert atmosphere
2: potassium hydroxide; potassium permanganate / water / 0 °C
3: N-ethyl-N,N-diisopropylamine; O-(benzotriazol-1-yl)-N,N,N,N-tetramethyluroniumhexafluorophosphate / dichloromethane / -15 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 1.25 h / 0 - 20 °C
5: butan-1-ol / Reflux
View Scheme

Doxazosin Specification

The Doxazosin, with the CAS registry number 74191-85-8, has the systematic name of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](2,3-dihydro-1,4-benzodioxin-2-yl)methanone. Its classification codes are: Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-antagonists; Antihypertensive agents; Cardiovascular Agents; Neurotransmitter Agents. The molecular formula of this chemical is C23H25N5O5.

The physical properties of Doxazosin are as following: (1)ACD/LogP: 0.65; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): -0.33; (4)ACD/LogD (pH 7.4): 0.6; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1.65; (7)ACD/KOC (pH 5.5): 5.62; (8)ACD/KOC (pH 7.4): 48.37; (9)#H bond acceptors: 10; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 89.49 Å2; (13)Index of Refraction: 1.657; (14)Molar Refractivity: 121.23 cm3; (15)Molar Volume: 329.2 cm3; (16)Polarizability: 48.06×10-24cm3; (17)Surface Tension: 64.9 dyne/cm; (18)Density: 1.371 g/cm3; (19)Flash Point: 388 °C; (20)Enthalpy of Vaporization: 104.92 kJ/mol; (21)Boiling Point: 718 °C at 760 mmHg; (22)Vapour Pressure: 1.83E-20 mmHg at 25°C.

Preparation of Doxazosin: It can be prepared by 4-Amino-2-chloro-6,7 -dimethoxy-quinazoline and 2-(1-carboxymethyl piperazine carbonyl)-1,4-Benzodioxan.

Doxazosin can be prepared by 4-Amino-2-chloro-6,7 -dimethoxy-quinazoline and 2-(1-carboxymethyl piperazine carbonyl)-1,4-Benzodioxan

Uses of Doxazosin: It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia. It is a kind of alpha-1 adrenergic receptor blocker that inhibits the binding of norepinephrine to the alpha-1 receptors on the membrane of vascular smooth muscle cells. And this primary effect of the inhibition is relaxed vascular smooth muscle tone, which decreases peripheral vascular resistance, leading to decreased blood pressure.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(N3CCN(c2nc1cc(OC)c(OC)cc1c(n2)N)CC3)C4Oc5c(OC4)cccc5
(2)InChI: InChI=1/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)
(3)InChIKey: RUZYUOTYCVRMRZ-UHFFFAOYAW

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 74191-85-8